Michael D. Iglesia

Suggest Changes
Learn More
PURPOSE Dual human epidermal growth factor receptor 2 (HER2) targeting can increase pathologic complete response rates (pCRs) to neoadjuvant therapy and improve progression-free survival in(More)
A screening for PGPRs was carried out in the rhizosphere of wild populations of Cistus ladanifer. Two hundred and seventy bacteria were isolated, purified and grouped by morphological criteria. Fifty(More)
  • 1